Pfizer Non Disclosure Agreement

Pfizer Non Disclosure Agreement: What You Need to Know

Pfizer Inc., the pharmaceutical company that developed the COVID-19 vaccine, has been in the news lately for its non disclosure agreements (NDAs). These NDAs are meant to protect Pfizer`s trade secrets and confidential information from being disclosed to competitors or the public. Here`s what you need to know about Pfizer`s NDAs and their implications.

What is a Non Disclosure Agreement?

A non disclosure agreement (NDA) is a legal contract between two or more parties stating that confidential information will not be shared with third parties. NDAs are commonly used by businesses to protect their intellectual property, trade secrets, and other sensitive information.

Pfizer`s NDAs

Pfizer has been requiring NDAs from countries that have purchased its COVID-19 vaccine. These agreements prohibit the disclosure of certain information related to the vaccine, including the price per dose, delivery schedules, and manufacturing processes. Pfizer argues that these NDAs are necessary to protect its intellectual property rights and to prevent competitors from using the company`s confidential information to gain an unfair advantage in the market.

Implications of Pfizer`s NDAs

Critics of Pfizer`s NDAs argue that they create a lack of transparency and accountability in the distribution of the COVID-19 vaccine. Some have also raised concerns that these agreements could lead to higher prices for the vaccine, as the lack of transparency makes it difficult for governments to negotiate prices effectively.

Moreover, Pfizer has been criticized for seeking legal protections against any possible adverse reactions or side effects resulting from the use of its vaccine, despite assurances from healthcare professionals that the vaccine is safe and effective.


The use of NDAs is a common practice for businesses to protect their confidential information. However, in cases where such NDAs could potentially harm public health or undermine transparency, it is important for companies to be transparent about their practices. Pfizer`s NDAs have raised concerns about transparency and accountability in the distribution of the COVID-19 vaccine. As governments and healthcare organizations continue to work towards increasing access to the vaccine, it is important for companies to balance their intellectual property rights with the public interest and safety.